US Patent 9364471 Compositions and methods of treating retinal disease
Patent 9364471 was granted and assigned to Aldeyra Therapeutics on June, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9364471 Compositions and methods of treating retinal disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
